Page 1

ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email!

Invega ' Analysis and Forecasts from 2007 to 2020 Published on October 2011

Report Summary Invega ' Analysis and Forecasts from 2007 to 2020 Summary GlobalData's pharmaceuticals report, 'Invega ' Analysis and Forecasts from 2007 to 2020' provides Invega sales estimates for US and EU5 . In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2007-2020). The report also includes information on Schizophrenia Disease market. This report is built using data and information sourced from GlobalData's proprietary databases, primary and secondary research using Company's corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope - Therapy area profile including patient population for the US, EU5 and Japan (seven major markets) - Analysis and review of Invega including historical sales data - Qualitative and quantitative assessment of market space - Analysis of the trends, drivers and restraints shaping and defining the markets - In-depth analysis of Invega including efficacy, safety, pricing, competition and other details which influence its sales potential - Detailed sales forecast for 2011-2020 for Invega in each of the seven major markets Reasons to buy - Understand and capitalize by identifying products that are most likely to ensure a robust return - Stay ahead of competition by understanding the changing competitive landscape - Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential - Make more informed business decisions from insightful and in-depth analysis of the drug's performance - Examine the historical sales performance of a drug in seven major markets - Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets

Table of Content 1 Table of Contents 1 Table of Contents 2 1.1 List of Tables 3 1.2 List of Figures 3 2 Introduction 4 2.1 Schizophrenia 4 2.2 Symptoms 4

Invega ' Analysis and Forecasts from 2007 to 2020 (From Issuu)

Page 1/5


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! 2.3 Schizophrenia Market 4 2.4 Epidemiology 4 2.5 Etiology 5 2.5.1 Genetic Factors 5 2.5.2 Environmental Factors 5 2.5.3 Abnormal Brain Structure 6 2.6 GlobalData Report Guidance 6 3 Schizophrenia: Market Characterization 7 3.1 Schizophrenia Market 7 3.2 Schizophrenia Market Forecasts and CAGR 7 3.3 Drivers of Schizophrenia Therapeutics Market 8 3.3.1 Patent Expiry of Leading Marketed Drugs 8 3.3.2 Increasing Patient Pool 8 3.3.3 High Prescription Rates 8 3.3.4 Low Patient Compliance Rate 8 3.3.5 High Unmet Need 8 4 Classification of Schizophrenia 9 4.1 Age of Onset of Schizophrenia 9 4.1.1 Pediatric / Adolescent / Childhood Schizophrenia 9 4.1.2 Adult Schizophrenia 10 4.2 Associated Symptoms 10 4.2.1 Paranoid Schizophrenia 10 4.2.2 Disorganized Schizophrenia 10 4.2.3 Catatonic Schizophrenia 10 4.2.4 Residual Schizophrenia 10 4.2.5 Undifferentiated Disorder 10 5 Treatment for Schizophrenia 11 5.1 Crisis Resolution Teams (CRT) 11 5.2 Voluntary and Compulsory Detention 11 5.3 Antipsychotics 11 5.3.1 Typical Antipsychotics 11 5.3.2 Atypical Antipsychotics 12 5.3.3 Increased Mortality in Elderly Patients with Dementia-Related Psychosis 12 6 Invega 13 6.1 Introduction 13 6.2 Mechanism of Action 13 6.3 Clinical Studies 13 6.4 Invega Approval History 14 6.5 Factors Affecting Sales of Invega 14 6.5.1 High Efficacy 14 6.5.2 Reluctance of Doctors to shift their Patients to another Therapy 14 6.5.3 High Competition 14 6.5.4 Absence in Japan 14 6.6 Drug Evaluation 15 6.6.1 Drug Risk Benefit Score 15 6.6.2 Intensity of Competition 16 6.7 Sales Forecasts 17 6.7.1 Target Patient Pool of Invega 17

Invega ' Analysis and Forecasts from 2007 to 2020 (From Issuu)

Page 2/5


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! 6.7.2 Dosing 17 6.7.3 Market Penetration 17 6.7.4 Annual Cost of Therapy 18 6.7.5 Sales Projections of Invega 18 7 Schizophrenia Market: Appendix 26 7.1 Market Definitions 26 7.2 Abbreviations 26 7.3 Research Methodology 26 7.4 Drug Sales Estimates Model 28 7.5 Contact Us 28 7.6 Disclaimer 29 7.7 Sources 29 1.1 List of Tables Table 1: Invega, Phase III Clinical Trial Results 13 Table 2: Drug Risk Benefit Score of Invega 15 Table 3: Competitors of Invega 16 Table 4: Invega, Annual Treatment Costs for Schizophrenia ($), 2011 18 Table 5: Invega, Schizophrenia, Global, Sales Forecasts ($m), 2007'2020 18 Table 6: Invega, Schizophrenia, The US, Sales Forecasts ($m), 2007'2020 19 Table 7: Invega, Schizophrenia, The UK, Sales Forecasts ($m), 2007'2020 20 Table 8: Invega, Schizophrenia, France, Sales Forecasts ($m), 2007'2020 21 Table 9: Invega, Schizophrenia, Germany, Sales Forecasts ($m), 2007'2020 22 Table 10: Invega, Schizophrenia, Italy, Sales Forecasts ($m), 2007'2020 23 Table 11: Invega, Schizophrenia, Spain, Sales Forecasts ($m), 2007'2020 24 1.2 List of Figures Figure 1: Risk of Developing Schizophrenia 5 Figure 2: Environmental Factors in the Development of Schizophrenia 6 Figure 3: Schizophrenia, Global, Market Size Forecasts ($bn), 2010'2020 7 Figure 4: Classification of Schizophrenia based on the Age of Disease Onset 9 Figure 5: Reduction in PANSS Scores for Atypical Antipsychotics 16 Figure 6: Drug Model Diagram of Invega 17 Figure 7: Invega, Schizophrenia, Global, Sales Forecasts ($m), 2007'2020 18 Figure 8: Invega, Schizophrenia, The US, Sales Forecasts ($m), 2007'2020 19 Figure 9: Invega, Schizophrenia, The UK, Sales Forecasts ($m), 2007'2020 20 Figure 10: Invega, Schizophrenia, France, Sales Forecasts ($m), 2007'2020 21 Figure 11: Invega, Schizophrenia, Germany, Sales Forecasts ($m), 2007'2020 22 Figure 12: Invega, Schizophrenia, Italy, Sales Forecasts ($m), 2007'2020 23 Figure 13: Invega, Schizophrenia, Spain, Sales Forecasts ($m), 2007'2020 24 Figure 14: Invega, Schizophrenia, Global, Sales Distribution in Major Countries (%), 2011 25

Invega ' Analysis and Forecasts from 2007 to 2020 (From Issuu)

Page 3/5


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ

Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93

If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information Please verify that the product information is correct and select the format(s) you require. Invega ' Analysis and Forecasts from 2007 to 2020

Product Formats Please select the product formats and the quantity you require. 1 User License--USD 2 000.00

Quantity: _____

Site License--USD 4 000.00

Quantity: _____

Corporate License--USD 6 000.00

Quantity: _____

Contact Information Please enter all the information below in BLOCK CAPITALS

Title:

Mr

Mrs

Dr

Miss

Ms

Prof

First Name:

_____________________________ Last Name: __________________________________

Email Address:

__________________________________________________________________________

Job Title:

__________________________________________________________________________

Organization:

__________________________________________________________________________

Address:

__________________________________________________________________________

City:

__________________________________________________________________________

Postal / Zip Code:

__________________________________________________________________________

Country:

__________________________________________________________________________

Phone Number:

__________________________________________________________________________

Fax Number:

__________________________________________________________________________

Invega ' Analysis and Forecasts from 2007 to 2020 (From Issuu)

Page 4/5


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card

Card Number: ______________________________________________

Expiry Date

__________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer

Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check

UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

 

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms

Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56

ƒ ƒ

Asia, Oceania and America : + 1 (805) 617 17 93

Invega ' Analysis and Forecasts from 2007 to 2020 (From Issuu)

Page 5/5


Invega Analysis and Forecasts from 2007 to 2020  

Invega ' Analysis and Forecasts from 2007 to 2020SummaryGlobalData's pharmaceuticals report, 'Invega ' Analysis and Forecasts from 2007...

Advertisement
Read more
Read more
Similar to
Popular now
Just for you